ABEO Market Cap History
Below is a table of the ABEO market cap history going back to 10/24/2014:

Date ABEO Market Cap
10/24/20145.33M
11/14/20143.76M
12/19/201449.90M
3/30/201562.37M
5/14/2015202.40M
8/14/2015174.89M
11/16/2015128.97M
3/30/201687.10M
5/16/201679.04M
8/15/2016131.16M
11/14/2016295.70M
3/30/2017201.28M
5/15/2017249.58M
8/11/2017304.17M
11/13/2017687.60M
3/15/2018720.21M
5/10/2018891.70M
8/9/2018697.57M
11/9/2018448.76M
3/13/2019356.27M
5/6/2019394.28M
8/5/2019120.33M

Also see: ABEO Shares Outstanding History
and ABEO YTD Return
ABEO Historical Market Cap:
+91.89% CAGR
ABEO Historical Market Cap: +91.89% CAGR

Mouse over chart for data details
10/24/2014 ...8/5/2019
Abeona Therapeutics is a clinical-stage biopharmaceutical company developing cell and gene therapies for life-threatening rare genetic diseases. Co.'s main programs include EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa, ABO-102, an adeno-associated virus-based gene therapy for Sanfilippo syndrome type A, and ABO-101 an AAV-based gene therapy for Sanfilippo syndrome type B. Co. is also developing ABO-202 and ABO-201, which are AAV-based gene therapies for the CLN1 and CLN3 forms of Batten Disease, respectively, ABO-401 for the treatment of cystic fibrosis, and ABO-5OX for the treatment of retinal diseases. We show 22 historical shares outstanding datapoints in our ABEO shares outstanding history coverage, used to compute ABEO market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ABEO market cap history over the course of time is important for investors interested in comparing ABEO's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ABEO versus a peer is one thing; comparing ABEO market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ABEO can fluctuate over the course of history. With this page we aim to empower investors researching ABEO by allowing them to research the ABEO market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ABEO:
ABEO SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Abeona Therapeutics (ABEO) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ABIO Market Cap History
ABMD Market Cap History
ABT Market Cap History
ACAD Market Cap History
ACER Market Cap History
ACET Market Cap History
ACHC Market Cap History
ACHN Market Cap History
ACHV Market Cap History
ACOR Market Cap History
More Healthcare companies »

 

ABEO Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2019, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.